US Patent Issued to Allgenesis Biotherapeutics on June 3 for "VEGFR fusion protein pharmaceutical composition" (Taiwanese, American Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,428, issued on June 3, was assigned to Allgenesis Biotherapeutics Inc. (Taipei, Taiwan).

"VEGFR fusion protein pharmaceutical composition" was invented by Tan Nguyen (Fullerton, Calif.), Pei-Tzu Wu (Taipei, Taiwan), Yung-Sheng Chang (Taipei, Taiwan) and Madhu Cherukury (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a biologic that inhibits angiogenesis. In particular, the present invention relates to fusion proteins that inhibit the integrin activated pathway and one other angiogenic factor-activated pathway as well as formulation compositions of such fusion proteins, as well as methods for producing a...